Back to Top Skip to main content Skip to sub-navigation

Surveillance for Vector-borne Diseases Among Active and Reserve Component Service Members, U.S. Armed Forces, 2016–2020

This image depicts a dorsal view of a female lone star tick, Amblyomma americanum, and is found in the Southeastern, and Mid-Atlantic United States. Females exhibit the star-like spot on their distal scutum. This tick is a vector of several zoonotic diseases, including human monocytic ehrlichiosis, and Rocky Mountain spotted fever (RMSF).  CDC/Michael L. Levin, PhD This image depicts a dorsal view of a female lone star tick, Amblyomma americanum, and is found in the Southeastern, and Mid-Atlantic United States. Females exhibit the star-like spot on their distal scutum. This tick is a vector of several zoonotic diseases, including human monocytic ehrlichiosis, and Rocky Mountain spotted fever (RMSF).

CDC/Michael L. Levin, PhD

Recommended Content:

Medical Surveillance Monthly Report

WHAT ARE THE NEW FINDINGS?

In the last decade, the most common vector-borne diseases among U.S. Armed Forces tended to be Lyme disease, malaria, Rocky Mountain spotted fever, dengue, and leishmaniasis. During 2014–2016, the pandemics of chikungunya and Zika virus transiently inserted those diseases into the top 5. The declining incidences of malaria and leishmaniasis during 2016–2020 are likely due to reduced numbers of service members assigned to endemic regions of the world.

WHAT IS THE IMPACT ON READINESS AND FORCE HEALTH PROTECTION?

The current findings reemphasize that the threat to service members from vector-borne diseases will vary according to the prevalent endemic diseases of specific geographic locations, the availability of protective vaccines, and the implementation of individual and group preventive measures.

ABSTRACT

This report summarizes data from electronic reports of reportable medical events (RMEs) to examine the incidence of vector-borne infectious diseases among members of the U.S. Armed Forces during a recent 5-year period. Case reports of such diseases were characterized as confirmed, probable, or suspected by the senders of the RME reports. Records of inpatient and outpatient care were not searched to find additional cases. Lyme disease and malaria were the most common diagnoses among confirmed cases. The next most common diagnoses were Zika virus infection, Rocky Mountain spotted fever, and dengue. Those 5 diseases were responsible for 94% of all confirmed vector-borne diseases reported as RMEs. Among the 1,068 RMEs for vector-borne diseases (confirmed, probable, and suspected), there were only 105 such cases that could be linked to a record of hospitalization for the same diagnosis.

BACKGROUND

The U.S. Armed Forces and the Department of Defense (DoD) have traditionally dedicated considerable effort to the prevention and treatment of vector-borne diseases that may adversely affect the ability of military service members to train for and execute their operational mission. A continuing element of that effort has been the performance of surveillance of vector-borne illnesses to guide preventive actions. The pages of the MSMR reflect over 25 years of surveillance studies to inform military leaders and preventive medicine/public health assets about the incidence of vector-borne diseases and appropriate steps to counter the associated threat. The February 2018 issue of the MSMR contained the results of the most recent, broad surveillance study of the most concerning vector-borne diseases.1 This article presents an updated review of this subject, utilizing a modified methodology for capturing the occurrence of cases.

METHODS

The surveillance period was 1 January 2016 through 31 December 2020. The surveillance population included all active and reserve component service members in the Army, Navy, Air Force, or Marine Corps who served at any time during the surveillance period. It is DoD policy that cases of certain specified medical conditions and events of public health importance shall be reported electronically through military health channels for surveillance purposes.2 Conditions covered by this policy are referred to as reportable medical events (RMEs). The content of such electronic reports is stored in the databases of the Defense Medical Surveillance System (DMSS), which was used to ascertain cases for this analysis. The vector-borne diseases that are the focus of this report are listed in Table 1. Almost all vector-borne diseases of concern for military service members are designated as RMEs.

For this analysis, a “confirmed”, “probable”, or “suspected” case was defined as an individual identified through an RME report of a vector-borne disease that was described as “confirmed”, “probable”, or “suspect” by having met specified laboratory or epidemiologic criteria.2 An individual could be counted once per lifetime for each type of vector-borne disease. For example, an individual could be counted once for malaria and once for leishmaniasis during the surveillance period. Individuals diagnosed as a case prior to the start of the surveillance period were excluded. Confirmed cases were prioritized over probable and suspected cases, respectively. 

A case was considered to be hospitalized if they had an inpatient admission within 30 days before or after the date of onset reported in the RME. In addition, the inpatient record had to include a diagnosis for the vector-borne disease as listed in Table 1 in any of the diagnostic positions. The total number of cases hospitalized, as well as the percentage hospitalized and number of bed days were summarized for each vector-borne disease.

RESULTS

During the 5-year surveillance period, the electronic records of RMEs identified 709 confirmed cases of vector-borne diseases, 196 probable cases, and 163 suspected cases among service members of the active and reserve components (Table 2). Active component service members comprised 86% of confirmed cases, 84% of probable cases, and 83% of suspected cases. There were no RMEs for any of the diagnoses of hemorrhagic fevers, filariasis, plague, relapsing fever, or yellow fever. The category “Arboviral diseases, neuro-invasive and non-neuroinvasive” included 3 cases of confirmed West Nile virus infection, 1 case of confirmed tick born encephalitis (TBE), and 4 unspecified types, for a total of 8 confirmed cases in that category. Only the 14 diagnostic categories displayed in Table 2 had any RMEs during the 5-year period.

Of the total of 709 confirmed cases, 668 (94%) were associated with RME diagnoses of Lyme disease (n=311), malaria (n=172), Zika virus infection (n=80), Rocky Mountain spotted fever (RMSF) (n=54), and dengue fever (n=51). The other diagnoses that were reported as confirmed cases were much less commonly documented (Table 2).

The distribution of diagnoses among probable RME cases was different from that of confirmed cases. It was noteworthy that Lyme disease was the diagnosis for 53 (27%) of the 196 probable cases, but RMSF accounted for 116 (59%) of the total probable cases. None of the other diagnoses was reported more than 5 times as probable cases during the 5 year surveillance period (Table 2).

Among the suspected cases, the most common RMEs were for Lyme disease (n=74), RMSF (n=54), and Zika virus infection (n=14). Together those three diagnoses were the subject of 87% of suspected cases of RMEs (Table 2). For the results described below, the emphasis will be on confirmed cases.

Lyme disease

Lyme disease accounted for 43.8% of all confirmed RME cases and was the most common of the vector-borne diseases reported during 2016–2020. The annual numbers of confirmed cases were greatest in 2016 and lowest in 2018, when the number of Lyme disease cases was actually lower than the count of malaria cases (Figure 1). The numbers of probable and suspected cases of Lyme disease (n=127) were actually lower than the counts for RMSF (n=170) during the surveillance period (Table 2).

Malaria

Diagnoses of malaria (n=172) contributed 24.2% of all confirmed RME cases of vector-borne diseases during the 5 year surveillance period. The highest count was in 2018 (n=51) but the most recent two years had the lowest counts of the period (n=26 and 20, respectively) (Figure 1). There were only 12 cases of malaria in RME reports of probable and suspected cases (Table 2).

Zika virus infection

Confirmed cases of Zika virus infection numbered 80 during the period (Table 2). However, 73 of those cases were reported in 2016, with the remainder reported in 2017 (n=4), 2019 (n=2), and 2020 (n=1) (data not shown). Zika virus was introduced into the Americas in 2015 and the case counts in the U.S. as well as in the U.S. Armed Forces peaked in 2016.3 Of the 16 service member cases reported as probable or suspected, 12 were reported in 2016 (data not shown).

Rocky Mountain spotted fever

Confirmed cases of RMSF (n=54), unlike all other diagnoses that are reportable, were outnumbered by reports of probable (n=116) and suspected (n=54) cases of RMSF (Table 2). This phenomenon is likely the result of the necessity to confirm the diagnosis of RMSF (and related rickettsial diseases) via the performance of acute and convalescent serological studies or other more sophisticated tests such as a PCR test for DNA, immunohistochemistry of a biopsy specimen, or a positive culture. The current RME guidelines include RMSF in the broader category of Spotted Fever Rickettsiosis, which includes conditions with similar clinical presentations that may be distinguished only with the testing procedures mentioned above.

Dengue

Of the total of 60 cases of dengue reported via RME, 51 were described as confirmed (Table 2). At least 18 of those confirmed cases were reported by an overseas treatment facility and an additional 14 cases were linked to an overseas travel location. The most commonly cited of those locations were Djibouti (n=7) and the Philippines (n=5). There were relatively few RME cases of dengue that were classified as probable (n=5) or suspected (n=4) (data not shown).

Leishmaniasis

There were 16 confirmed cases of leishmaniasis reported during the period but only 2 of them were reported in 2019 and none in 2020 (Table 2, data not shown). Of the 6 cases for which the reports mention a location where the service member may have acquired the infection, 5 specify either Iraq, Afghanistan, or Syria and 1 mentions Palau (data not shown). Probable cases numbered 2 and there were no suspected cases.

Arboviral diseases, neuroinvasive and nonneuroinvasive

The 3 confirmed cases and 1 suspected case of West Nile virus infection were diagnosed in the continental U.S. and the single confirmed and probable cases of tick-borne encephalitis were diagnosed in Germany (data not shown). Among the total of 12 cases that were reported in this broad category, 7 were associated with Germany and 5 with the U.S. (data not shown).

Other

The remaining 5 diagnostic categories of RMEs were associated with a total of 17 confirmed cases, 12 probable cases, and 7 suspected cases over the 5-year surveillance period (Table 2). The most recent confirmed cases of chikungunya were 2 that were diagnosed in 2019 and they were associated with recent travel to the Philippines and Djibouti, respectively (data not shown).

Hospitalizations

During the 5-year surveillance period, there were 1,068 RME reports submitted for confirmed, probable, and suspected cases. Associated with the service members who were the subjects of those reports, there were 105 instances of hospitalization for which the records of inpatient care specified the diagnosis of the reportable condition. Such hospitalizations reflected only 6 different reportable diagnoses (Table 3). Of the 184 reported cases of malaria, 43.5% were associated with hospitalizations (n=80) for which a malaria diagnosis was recorded. For Lyme disease, the 11 hospitalizations represented 2.5% of all RME diagnoses of that condition; for dengue, the 7 hospitalizations were associated with 11.7% of all RME diagnoses; for arboviral diseases, there were 4 hospitalizations representing 33.3% of all cases that were reported. Finally, there were single hospitalizations for RMSF and typhus that represented .4% and 20% of RMEs for those respective diagnoses (Table 3).

EDITORIAL COMMENT

The identities of the most common vector-borne diseases in this analysis were similar to those documented in previous studies. For example, MSMR reports covering the years 1995–1999 and 2010–2016 noted that the most common diseases included Lyme disease, malaria, RMSF, dengue fever, and leishmaniasis, just as was the case for 2016–2020.1,4 The only exceptions to the lists of most common diseases were due to the pandemic occurrences of chikungunya and Zika virus infections starting in 2013.3,5

The methods employed in this surveillance study differed significantly from the two studies previously mentioned. The counts for 2016–2020 were based solely on RMEs electronically submitted by public health/preventive medicine specialists who evaluated the available information for each case in order to render an evaluation as to whether or not the diagnosis was confirmed, probable, or suspected. The previous studies utilized DMSS records of hospitalizations and/or outpatient encounters to identify cases. It is most noteworthy that using only the documentation of outpatient diagnoses to qualify as a “suspected” case, as was one of the criteria in 2010–2016, is a highly sensitive, but very non-specific means of identifying cases. The employment of just RMEs to identify and count cases of vector-borne diseases increases the probability they are true cases of the diseases of interest. However, the omission of inpatient and outpatient diagnoses of these diseases likely yields an underestimate of the true incidence of some of the conditions.

The analysis of hospitalizations among RME cases revealed that most reportable vector-borne diseases were not associated with a hospitalization within 30 days before or after the reported date of illness onset. The correlation between hospitalization and diagnosis of a reportable disease is mainly a reflection of the severity of illness. The diseases of interest in this study have a broad spectrum of clinical severity and, in particular, if a given disease can be readily treated with a highly effective antimicrobial agent, then rates of hospitalization may be quite low.

The reader is referred to the February 2018 MSMR article on this subject for further discussion of the topics of Lyme disease incidence in the U.S., the years of peak incidence of chikungunya and Zika virus infections, the declining incidence of leishmaniasis associated with reduced presence of service members in the Middle East, and the pitfalls of using outpatient diagnoses for surveillance.1

REFERENCES

1. O’Donnell FL, Stahlman S, Fan M. Surveillance for vector-borne diseases among active and reserve component service members, U.S. Armed Forces, 2010–2016. MSMR. 2018;25:8–15.

2.  Defense Health Agency. Armed Forces Reportable Medical Events. Guidelines and Case Definitions. January 2020.

3.  Ikejezie J, Shapiro CN, Kim J, et al. Zika virus transmission–Region of the Americas, May 15, 2015 – December 15, 2016. MMWR Morb Mortal Wkly Rep. 2017;66:329–334.

4.  Garvey AL. Five most common arthropodborne diseases among active duty service members in the U.S. Armed Forces, 1995-1999. MSMR. 2000;6:12–16.

5.   Fischer M, Staples JE. Notes from the field. Chikungunya virus spreads in the Americas – Caribbean and South America, 2013–2014. MMWR Morb Mortal Wkly Rep. 2014:63:500–501.

FIGURE. Annual counts of confirmed cases of most common RMEs, active and reserve components, U.S. Armed Forces, 2016–2020

TABLE 1. Reportable vector-borne diseases, with ICD-10 diagnostic codes, type of infectious agent, type of vectors, geographic distribution, and availability of FDA-approved vaccine

TABLE 2. Numbers of confirmed, probable, and suspected cases of vector-borne diseases, active and reserve components, U.S. Armed Forces, 2016–2020

TABLE 3. Frequency of hospitalizations of service members with RMEs for vector-borne diseases and associated number of hospital bed days, active and reserve components, U.S. Armed Forces, 2016–2020

You also may be interested in...

Disparities in COVID-19 Vaccine Initiation and Completion Among Active Component Service Members and Health Care Personnel, 11 December 2020–12 March 2021

Article
4/1/2021
Capt. Shamira Conerly, 149th Medical Group, gives Staff Sgt. Timmy Sanders, 149th Maintenance Squadron, his first does of COVID-19 vaccine on Joint Base San Antonio-Lackland, Texas, March 18, 2021. Members of the 149th Fighter Wing who have opted to receive their vaccine have been scheduled over the past two weeks by the 149th Medical Group. (US Air National Guard Photo by Senior Airman Ryan Mancuso)

Recommended Content:

Medical Surveillance Monthly Report

Update: Heat Illness, Active Component, U.S. Armed Forces, 2020

Article
4/1/2021
Fort Jackson, SC. A trainee with 2nd Battalion, 60th Infantry Regiment puts his arms in an arm immersion cooling tank during training. The tanks allow Soldiers to rapidly cool by putting their forearms into a tank of ice water. (Photo by Saskia Gabriel)

Recommended Content:

Medical Surveillance Monthly Report

Update: Exertional Rhabdomyolysis, Active Component, U.S. Armed Forces, 2016–2020

Article
4/1/2021
Marine Corps Recruit Depot, San Diego  Recruits with Bravo Company, 1st Recruit Training Battalion, hydrate after a physical training session at Marine Corps Recruit Depot San Diego, April 12, 2020. The recruits performed multiple exercises at different stations after completing a 400-meter dash. (U.S. Marine Corps photo by Cpl. Brooke C. Woods)

Recommended Content:

Medical Surveillance Monthly Report

Skin and Soft Tissue Infections, Active Component, U.S. Armed Forces, January 2016–September 2020

Article
4/1/2021
Detailed view of elbow with carbuncle or furuncle. iStock.com/andriano_cz

Recommended Content:

Medical Surveillance Monthly Report

Update: Exertional Hyponatremia, Active Component, U.S. Armed Forces, 2005–2020

Article
4/1/2021
Marine Corps Recruit Depot, San Diego  Recruits with Bravo Company, 1st Recruit Training Battalion, hydrate after a physical training session at Marine Corps Recruit Depot San Diego, April 12, 2020. The recruits performed multiple exercises at different stations after completing a 400-meter dash. (U.S. Marine Corps photo by Cpl. Brooke C. Woods)

Recommended Content:

Medical Surveillance Monthly Report

Influenza Outbreak During Exercise Talisman Sabre, Queensland, Australia, July 2019

Article
3/1/2021
Flight Lt. Michael Campion, an aviation medical officer from No. 3 Aeromedical Evacuation Squadron prepares a medical patient leaving Exercise Talisman Sabre to be transferred to a C-27J Spartan aircraft July 18, 2019 at Rockhampton Airport. No. 3 Aeromedical Evacuation Squadron is providing medical support to troops participating in Talisman Sabre 2019, a bilateral combined Australian and United States exercise designed to train respective military services in planning and conducting Combined and Joint Task Force operations, and improve the combat readiness and interoperability between Australian and US forces. (U.S. Army photo by Sgt. 1st Class John Etheridge)

Influenza Outbreak During Exercise Talisman Sabre, Queensland, Australia, July 2019

Recommended Content:

Medical Surveillance Monthly Report

Influenza Surveillance Trends and Influenza Vaccine Effectiveness Among Department of Defense Beneficiaries During the 2019–2020 Influenza Season

Article
3/1/2021
Captured in 2011, this transmission electron microscopic (TEM) image depicts some of the ultrastructural details displayed by H3N2 influenza virions, responsible for causing illness in Indiana and Pennsylvania in 2011. See PHIL 13469, for the diagrammatic representation of how this Swine Flu stain came to be, through the “reassortment” of two different Influenza viruses.  Credit: CDC/ Dr. Michael Shaw; Doug Jordan, M.A.

Influenza Surveillance Trends and Influenza Vaccine Effectiveness Among Department of Defense Beneficiaries During the 2019–2020 Influenza Season

Recommended Content:

Medical Surveillance Monthly Report

Update: Sexually Transmitted Infections, Active Component, U.S. Armed Forces, 2012–2020

Article
3/1/2021
Under a magnification of 1150X, this photomicrograph of a Gram-stained urethral discharge specimen, demonstrated the presence of Gram-negative, intracellular diplococci, which is a finding indicative of the possible presence of Neisseria gonorrhoeae bacteria.  Credit: CDC/ Dr. Caldwell

Update: Sexually Transmitted Infections, Active Component, U.S. Armed Forces, 2012–2020

Recommended Content:

Medical Surveillance Monthly Report

A Retrospective Cohort Study of Blood Lead Levels Among Special Operations Forces Soldiers Exposed to Lead at a Firing Range in Germany

Article
3/1/2021
A soldier assigned to the U. S. Army John F. Kennedy Special Warfare Center and School who is in the Special Forces Weapons Sergeant Course fires a pistol during small arms training at Fort Bragg, North Carolina November 4, 2019. The soldiers were trained to employ, maintain and engage targets with select U.S. and foreign pistols, rifles, shotguns, submachine and machine guns, grenade launchers and mortars and in the utilization of observed fire procedures. (U.S. Army photo illustration by K. Kassens)

Recommended Content:

Medical Surveillance Monthly Report

Update: Malaria, U.S. Armed Forces, 2020

Article
2/1/2021
Spc. Joshua Jones, left, and Pfc. Richard Bower, both preventive medicine specialists, 227th Preventive Medicine Detachment, 62nd Medical Brigade, check an insect trap during a field training exercise on Joint Base Lewis-McChord, June 20. The 227th PMD notionally deployed to Guiria, Venezuela, where a tropical storm caused floods and presented a real world concern for mosquitos, which are known to spawn in stagnant water and cause widespread vector borne illnesses such as malaria, yellow fever and dengue fever.  Photo by Sgt. Sarah Enos 5th Mobile Public Affairs Detachment

Recommended Content:

Medical Surveillance Monthly Report

Historical Perspective: The Evolution of Post-exposure Prophylaxis for Vivax Malaria Since the Korean War

Article
2/1/2021
An Aedes aegypti mosquito can transmit the viruses that cause dengue fever.  CDC/Prof. Frank Hadley Collins, Cntr. for Global Health and Infectious Diseases, Univ. of Notre Dame

Recommended Content:

Medical Surveillance Monthly Report

Attrition Rates and Incidence of Mental Health Disorders in an Attention-Deficit/Hyperactivity Disorder (ADHD) Cohort, Active Component, U.S. Armed Forces, 2014–2018

Article
1/1/2021
Capt. Michelle Tsai, the behavioral health officer for the 4th Brigade, 2nd Infantry Division, reviews medical information in her office at the Joint Readiness Training Center June 17. Tsai, an Alexandria, Va., native, is here with the Raider Brigade in support of training operations for the unit's upcoming deployment to Iraq. (Photo by Pfc. Luke Rollins)

Recommended Content:

Medical Surveillance Monthly Report

Exertional Rhabdomyolysis and Sickle Cell Trait Status in the U.S. Air Force, January 2009–December 2018

Article
1/1/2021
JOINT BASE SAN ANTONIO, Texas - Master Sgt. Daniel Bedford, Air Force Recruiting Service National Events program manager, prepares to pump up a gold medal lift in the bench press during the USPA (United State Powerlifting Association) 2020 Texas State Bench Press Championship. Senior Master Sgt. Michael Lear, AFRS Strategic Marketing Division superintendent, prepares to spot Bedford. Lear and Bedford are Total Force recruiting partners who train together and motivate one another at work and in the gym. (Courtesy photo) (Photo By: babin.)

Recommended Content:

Medical Surveillance Monthly Report

The Prevalence of Attention-Deficit/Hyperactivity Disorder (ADHD) and ADHD Medication Treatment in Active Component Service Members, U.S. Armed Forces, 2014–2018

Article
1/1/2021
New Recruits with Golf Company, 2nd Recruit Training Battalion, are screened after arriving at Marine Corps Recruit Depot, San Diego, Dec. 28, 2020. As recruits arrive to the depot in the future, they will enter a staging period of 14 days during which they will be medically screened, monitored, and provided classes to prepare and orient them to begin recruit training. All of this will occur before they step onto our iconic yellow footprints and make that memorable move toward earning the title Marine. Current planning and execution remain fluid as the situation continues to evolve. The health and well-being of our recruits, recruiting and training personnel, and their families remain our primary concerns. All recruits will be screened and tested for COVID-19 prior to beginning recruit training. (U.S. Marine Corps photo by Lance Cpl. Grace J. Kindred)

Recommended Content:

Medical Surveillance Monthly Report

Air Evacuation of Service Members for COVID-19 in U.S. Central Command and U.S. European Command From 11 March 2020 Through 30 September 2020

Article
12/1/2020
3-3D_Influenza_blue_no_key_pieslice_med: This illustration provides a 3D graphical representation of a generic Influenza virion’s ultrastructure, and is not specific to a seasonal, avian or 2009 H1N1 virus. (Credit: CDC/ Douglas Jordan)

Recommended Content:

Medical Surveillance Monthly Report
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 9

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.